.After antibody-drug conjugate (ADC) specialist Seagen was actually offered to Pfizer last year for ...
.On the heels of a stage 3 succeed that fell short to impress entrepreneurs, Ironwood Pharmaceutical...
.Don't cease Monte Rosa Therapeutics right now. The Boston-based biotech is having a ball after auth...
.Accept to this week's Chutes & Ladders, our summary of significant leadership hirings, shootings...
.Celebrating his provider's upsized initial public offering (IPO), Septerna CEO Jeffrey Finer rang t...
.AbbVie has actually returned to the resource of its own antipsychotic goliath Vraylar in search of ...
.GenSight Biologics is full weeks out of running out of cash. Once again. The biotech merely possess...
.Monopar Rehabs is actually recuperating a drug coming from the dump of AstraZeneca's rare condition...
.Along with new information out on Arcus Biosciences' speculative HIF-2a prevention, one group of pr...
.After developing a gene treatment partnership along with Dyno Rehabs in 2020, Roche is actually bac...